Vanderbilt to Use GenoLogics Software for Colorectal Cancer Research | GenomeWeb
NEW YORK (GenomeWeb News) - Vanderbilt University will use GenoLogics’ data-management software for research on colorectal cancer, the company said today.
 
Researchers at Vanderbilt’s Jim Ayers Institute for Precancer Detection and Diagnostics will use the company’s Proteus system in a program aimed at developing a blood test for early detection of colorectal cancers as well as therapies for targeted treatment of specific tumor types, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.